These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 28608917)

  • 1. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Gilbert DC; Wakeham K; Langley RE; Vale CL
    Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts.
    Blomberg M; Friis S; Munk C; Bautz A; Kjaer SK
    J Infect Dis; 2012 May; 205(10):1544-53. PubMed ID: 22427679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
    Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
    Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the burden of HPV-related cancers in Appalachia.
    Reiter PL; Fisher JL; Hudson AG; Tucker TC; Plascak JJ; Paskett ED
    Hum Vaccin Immunother; 2013 Jan; 9(1):90-6. PubMed ID: 23143774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
    Lam JO; Lim WY; Chow KY; D'Souza G
    PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.
    Neumann F; Jégu J; Mougin C; Prétet JL; Guizard AV; Lapôtre-Ledoux B; Bara S; Bouvier V; Colonna M; Troussard X; Trétarre B; Grosclaude P; Velten M; Woronoff AS
    Prev Med; 2016 Sep; 90():52-8. PubMed ID: 27370167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
    Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers.
    Wang M; Sharma A; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF; Huh WK; Adjei Boakye E
    Cancer Epidemiol; 2020 Feb; 64():101649. PubMed ID: 31816512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies.
    Skinner HD; Sturgis EM; Klopp AH; Ang KK; Rosenthal DI; Garden AS; Morrison WH; Gunn GB; Beadle BM
    Head Neck; 2014 Jun; 36(6):819-25. PubMed ID: 23720126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
    Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
    Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
    Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and burden of HPV-related disease.
    Serrano B; Brotons M; Bosch FX; Bruni L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
    Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.